DSIP (Delta Sleep-Inducing Peptide) dosing & administration
A naturally occurring brain peptide that helps you fall into deep, restorative sleep by gently nudging your body's own sleep-wake systems—without the groggy hangover of traditional sleep aids.
Written by Michael Carroll — Owner, Director of Research · Reviewed by the Peptide Initiative Research Team · Editorial standards
Dosing
How much do I take?
Subcutaneous: A small injection into the fatty layer just under the skin — the same way insulin is given.
Bioavailability High — most of the dose reaches your bloodstream, just more gradually than an IV.
3 documented dose levels — separate regimens, not a titration schedule
100 mcg
Frequency
Once daily, 1 hour before bed
Duration
1–2 weeks
200 mcg
Frequency
Once daily, 1 hour before bed
Duration
4–6 weeks
300 mcg
Frequency
Once daily, 1 hour before bed
Duration
2–4 weeks
Timing
Best time to take
Evening, 1-2 hours before your intended bedtime. DSIP doesn't knock you out instantly—it works with your body's natural sleep systems, so give it time to take effect.
With food?
Can be taken with or without food. Some people prefer taking it on an empty stomach for potentially faster absorption, but food doesn't block its effects.
If stacking
If using with other peptides like CJC-1295 or Ipamorelin for growth hormone support, inject at different sites. DSIP is typically taken alone in the evening while growth hormone peptides may be used at other times.
Adjusting your dose
Increase if
- You've been at the current dose for 2+ weeks with minimal improvement
- Sleep quality improved initially but has plateaued
- No side effects at current dose and you want better results
- Your healthcare provider recommends escalation
Decrease if
- You experience morning grogginess or headaches
- Sleep becomes too deep and you have trouble waking to alarms
- Vivid dreams become disturbing rather than pleasant
- Any uncomfortable side effects persist
Signs of right dose
- Falling asleep within 20-30 minutes of lying down
- Sleeping through the night with minimal waking
- Waking feeling refreshed without an alarm
- Improved daytime energy and mental clarity
Administration
How do I use it?
Reconstitution
What you need
Injection
Route
Subcutaneous injection (just under the skin)—simple and effective for self-administration
Best sites
Storage
Before reconstitution
Keep your DSIP powder in the freezer (-20°C/-4°F or colder). Store in its original sealed vial, protected from light. A properly stored vial can remain stable for up to 24 months. Never leave powder at room temperature for extended periods.
After reconstitution
Once mixed with bacteriostatic water, immediately refrigerate at 36-46°F (2-8°C). Keep the vial upright and away from light. Use within 28 days. Never freeze the reconstituted solution—this destroys the peptide.
Signs of degradation — discard the vial
Sample daily schedule
Evening (1-2 hours before bedtime)
100-300 mcg based on your tier injection
Site: Abdomen or thigh—rotate sites
Take at a consistent time each evening for best results. DSIP works with your natural sleep systems, so timing matters. Aim for the same window each night, ideally 1-2 hours before you want to be asleep. A 4-6 week cycle is typical, followed by a break to assess your sleep without it.
Safety
Is it safe?
Side effects
Commonly reported: Mild headache, Brief dizziness or lightheadedness, Flushing or warmth, Injection site reactions
Less common: Vivid dreams, Mild nausea
Stop and seek help if
- Any signs of allergic reaction—hives, swelling, breathing difficulty (stop immediately, seek help)
- Severe or persistent headaches that don't respond to dose reduction
- Excessive daytime drowsiness affecting your ability to function
- Unusual mood changes or psychological symptoms
- You've completed your planned cycle (typically 4-6 weeks)
- Your healthcare provider recommends discontinuation
DSIP is a research peptide, not an FDA-approved medication. Always work with a qualified healthcare provider when using peptides. Never start, stop, or change doses without professional guidance. This information is educational—not medical advice.
Flagged pairings
- Benzodiazepines (Xanax, Valium, etc.) — Both enhance sleep/sedation—combining could cause excessive drowsiness. Consult your doctor before using together.
- Z-drugs (Ambien, Lunesta) — Similar concern as benzodiazepines—additive sedation effects. Don't combine without medical supervision.
Published research
What the studies show
Schneider-Helmert D · 1987
In chronic insomniacs, DSIP substantially improved night sleep from the first dose and continued improving with repeated treatment. Efficiency of night sleep and daytime rest reached normal levels, and participants showed increased alertness and mental performance during the day.
Schneider-Helmert D, Schoenenberger GA · 1983
Human studies confirmed DSIP promotes natural sleep with effects lasting up to 20 hours after a single dose. Beyond sleep, DSIP improved daytime alertness, performance, stress tolerance, and coping ability—showing it does much more than just help you fall asleep.
Graf MV, Kastin AJ · 1981
In healthy volunteers, DSIP increased total sleep time by 59% during the day and improved subsequent night sleep quality. Importantly, there was no classic sedation—subjects maintained normal alertness when awake. The compound was well-tolerated with no psychological, physiological, or biochemical side effects.
Schneider-Helmert D, Schoenenberger GA · 1981
Chronic insomniacs receiving DSIP had longer sleep duration, higher quality sleep with fewer interruptions, and slightly more REM sleep—but no daytime sedation. The sleep-promoting effects lasted up to 6 hours through the night.
Bondarenko TI, Maĭboroda EA, Mikhaleva II · 2011
DSIP showed powerful antioxidant effects in aging rats, activating the body's natural antioxidant defense systems including superoxide dismutase, catalase, and ceruloplasmin. This suggests DSIP may have anti-aging benefits beyond just sleep improvement.
Monti JM, Debellis J, Alterwain P, Pellejero T, Monti D · 1987
A double-blind crossover study in chronic insomniacs, 25 nmol/kg intravenously across four nights. Night-time awakenings, time awake and time to fall into non-REM sleep all fell on DSIP, but none of those changes was significantly different from the patients' own baseline or from the double-blind placebo nights. Total sleep time and non-REM sleep did rise significantly versus placebo — but the same gap was already present in the baseline values. The authors concluded that the sleep improvement is "of little clinical significance."
Bes F, Hofman W, Schuur J, Van Boxtel C · 1992
Sixteen chronic insomniacs, double-blind, matched pairs, parallel groups, five consecutive nights in a sleep laboratory. Half received 25 nmol/kg DSIP intravenously in the afternoon before nights 3, 4 and 5; half received a glucose placebo. Sleep efficiency was higher and sleep latency shorter on DSIP. The authors judged those effects weak, noted they could in part be due to an incidental change in the placebo group, found no change in subjective sleep quality or any other measure, and concluded that short-term DSIP treatment of chronic insomnia is "not likely to be of major therapeutic benefit."
Spath-Schwalbe E, Schafer A, Uthgenannt D, Born J, Fehm HL · 1995
The only human study to test DSIP's reported stress-hormone effect directly. Healthy young men received DSIP intravenously — total doses of 3 and 4 mg — against placebo, first around a corticotropin-releasing hormone challenge (5 men per condition) and then around a midday meal (10 more men). ACTH and cortisol responses were almost identical on DSIP and on placebo in both experiments. The authors concluded their data "do not support an inhibitory role of DSIP on ACTH and cortisol secretion in man," which is the opposite of what had been reported in cells and in animals.
Head to head
DSIP (Delta Sleep-Inducing Peptide) compared
Studied for
Conditions DSIP (Delta Sleep-Inducing Peptide) has been researched in
Want the full picture?
The complete DSIP (Delta Sleep-Inducing Peptide) research profile: mechanism of action, clinical studies, effectiveness timeline, and FAQ.